Clinical Trial Update: LTFU Study of Subjects Who Received GRNOPC1

View source ↗

Summary

This clinical trial update reports a long-term follow-up study of subjects who received GRNOPC1 for spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• GRNOPC1

Snippet

Sponsor: Lineage Cell Therapeutics, Inc. | Conditions: Spinal Cord Injuries | Status: ACTIVE_NOT_RECRUITING